Turn Therapeutics (TTRX) Shares Outstanding (Weighted Average) (2024 - 2026)

Turn Therapeutics has reported Shares Outstanding (Weighted Average) for 3 years, with the latest figure at $29.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 9.35% year-over-year to $29.5 million; the trailing twelve-month figure through Mar 2026 stood at $29.5 million (up 9.35% YoY), and the FY2025 full-year result was $27.7 million, up 4.03% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $29.5 million, up from $27.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $29.5 million in Q1 2026, with the low at $26.6 million in Q4 2024.
• Average Shares Outstanding (Weighted Average) over 3 years is $27.6 million, with a median of $27.3 million recorded in 2025.
• Year-over-year, Shares Outstanding (Weighted Average) grew 4.03% in 2025 and increased 9.35% in 2026.
• Tracing TTRX's Shares Outstanding (Weighted Average) over 3 years: stood at $26.6 million in 2024, then climbed by 4.03% to $27.7 million in 2025, then gained by 6.35% to $29.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $29.5 million (Q1 2026), $27.7 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.

Peer Comparison